SANUWAVE Health, Inc. (SNWV)
Automate Your Wheel Strategy on SNWV
With Tiblio's Option Bot, you can configure your own wheel strategy including SNWV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SNWV
- Rev/Share 4.5776
- Book/Share -1.7257
- PB -17.6392
- Debt/Equity -0.08
- CurrentRatio 0.4337
- ROIC 0.5433
- MktCap 260810072.0
- FreeCF/Share -0.0124
- PFCF -2460.4724
- PE -6.8537
- Debt/Assets 0.0358
- DivYield 0
- ROE 1.448
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | SNWV | Northland Capital | -- | Outperform | -- | $55 | Sept. 3, 2025 |
| Initiation | SNWV | Roth Capital | -- | Buy | -- | $49 | July 29, 2025 |
News
Sanuwave Health Inc. (SNWV) to Report Q3 Results: Wall Street Expects Earnings Growth
Published: October 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Sanuwave Health (SNWV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Sanuwave: A Long-Term Compounder In Its Early Stages
Published: September 15, 2025 by: Seeking Alpha
Sentiment: Positive
Sanuwave's UltraMIST system is gaining significant traction for wound treatment, driven by its razor and razor blade business model. Q2 revenue grew 42% year over year, with full year guidance calling for 50% growth at the midpoint. Q2 gross margin was 78.3% and is expected to gradually increase in the coming quarters due to lower manufacturing costs.
Read More
SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call Transcript
Published: August 08, 2025 by: Seeking Alpha
Sentiment: Neutral
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q2 2025 Earnings Conference Call August 8, 2025 8:30 AM ET Company Participants Morgan C. Frank - CEO & Chairman Peter Sorensen - CFO & Secretary Conference Call Participants Albert Hanser - Unidentified Company Christopher Michael Plahm - Tall Pines Capital, LLC Kyle Royal Bauser - ROTH Capital Partners, LLC, Research Division Operator Good day, everyone, and welcome to the SANUWAVE Q2 Earnings Call.
Read More
Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
Published: June 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ:SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the hiring of Dustin Libby as its EVP of commercial operations.
Read More
About SANUWAVE Health, Inc. (SNWV)
- IPO Date 2009-09-30
- Website https://www.sanuwave.com
- Industry Medical - Devices
- CEO Morgan C. Frank
- Employees 46